103 related articles for article (PubMed ID: 10847548)
1. Expression of the pro-apoptotic caspase 3/CPP32 in cutaneous basal and squamous cell carcinomas.
Cousin F; Baldassini S; Bourchany D; Claudy A; Kanitakis J
J Cutan Pathol; 2000 May; 27(5):235-41. PubMed ID: 10847548
[TBL] [Abstract][Full Text] [Related]
2. Expression and activation of caspase-3/CPP32 in CD34(+) cord blood cells is linked to apoptosis after growth factor withdrawal.
Wang LS; Liu HJ; Xia ZB; Broxmeyer HE; Lu L
Exp Hematol; 2000 Aug; 28(8):907-15. PubMed ID: 10989191
[TBL] [Abstract][Full Text] [Related]
3. The pattern of CPP32/caspase-3 expression reflects the biological behavior of the human pancreatic duct cell tumors.
Satoh K; Kaneko K; Hirota M; Toyota T; Shimosegawa T
Pancreas; 2000 Nov; 21(4):352-7. PubMed ID: 11075989
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis.
Hoshi T; Sasano H; Kato K; Yabuki N; Ohara S; Konno R; Asaki S; Toyota T; Tateno H; Nagura H
Anticancer Res; 1998; 18(6A):4347-53. PubMed ID: 9891491
[TBL] [Abstract][Full Text] [Related]
5. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin.
Reichrath J; Welter C; Mitschele T; Classen U; Meineke V; Tilgen W; Seifert M
J Pathol; 2003 Apr; 199(4):509-16. PubMed ID: 12635142
[TBL] [Abstract][Full Text] [Related]
6. [CPP32 expression and its significance in multidrug-resistant tumor cells and their parent cells].
Wang SD; Zhang ZS; Zhang XQ; Zhou DY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):32-4. PubMed ID: 12390838
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma.
Fujikawa K; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Takase K; Nakano T
Anticancer Res; 2000; 20(3B):1927-32. PubMed ID: 10928128
[TBL] [Abstract][Full Text] [Related]
8. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells.
Posmantur R; McGinnis K; Nadimpalli R; Gilbertsen RB; Wang KK
J Neurochem; 1997 Jun; 68(6):2328-37. PubMed ID: 9166725
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of caspase-14 in epithelial tumors.
Koenig U; Sommergruber W; Lippens S
Biochem Biophys Res Commun; 2005 Sep; 335(2):309-13. PubMed ID: 16061209
[TBL] [Abstract][Full Text] [Related]
11. Wild-type p53-dependent etoposide-induced apoptosis mediated by caspase-3 activation in human glioma cells.
Yin D; Tamaki N; Kokunai T
J Neurosurg; 2000 Aug; 93(2):289-97. PubMed ID: 10930016
[TBL] [Abstract][Full Text] [Related]
12. Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study.
de Bilbao F; Guarin E; Nef P; Vallet P; Giannakopoulos P; Dubois-Dauphin M
J Comp Neurol; 1999 Jul; 409(3):339-57. PubMed ID: 10379822
[TBL] [Abstract][Full Text] [Related]
13. Elevated c-Src and c-Yes expression in malignant skin cancers.
Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kim CH; Kang SG; Lee YJ; Park MY; Jeong DJ; Cho MK
J Exp Clin Cancer Res; 2010 Aug; 29(1):116. PubMed ID: 20796316
[TBL] [Abstract][Full Text] [Related]
14. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells.
Faleiro L; Kobayashi R; Fearnhead H; Lazebnik Y
EMBO J; 1997 May; 16(9):2271-81. PubMed ID: 9171342
[TBL] [Abstract][Full Text] [Related]
15. Caspase 3 in breast cancer.
O'Donovan N; Crown J; Stunell H; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Clin Cancer Res; 2003 Feb; 9(2):738-42. PubMed ID: 12576443
[TBL] [Abstract][Full Text] [Related]
16. CPP32/CASPASE-3-like proteases in hypoxia-induced apoptosis in developing brain neurons.
Bossenmeyer-Pourié C; Koziel V; Daval JL
Brain Res Mol Brain Res; 1999 Aug; 71(2):225-37. PubMed ID: 10521577
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign nodular hyperplasias.
Sohn JH; Kim DH; Choi NG; Park YE; Ro JY
Histopathology; 2000 Dec; 37(6):555-60. PubMed ID: 11122438
[TBL] [Abstract][Full Text] [Related]
18. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells.
Kurokawa H; Nishio K; Fukumoto H; Tomonari A; Suzuki T; Saijo N
Oncol Rep; 1999; 6(1):33-7. PubMed ID: 9864397
[TBL] [Abstract][Full Text] [Related]
19. HPV+ cervical carcinomas and cell lines display altered expression of caspases.
Aréchaga-Ocampo E; Pereira-Suárez AL; del Moral-Hernández O; Cedillo-Barrón L; Rodríguez-Sastre MA; Castillo-Alvarez A; López-Bayghen E; Villegas-Sepúlveda N
Gynecol Oncol; 2008 Jan; 108(1):10-8. PubMed ID: 17936882
[TBL] [Abstract][Full Text] [Related]
20. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.
Pyke C; Ralfkiaer E; Huhtala P; Hurskainen T; Danø K; Tryggvason K
Cancer Res; 1992 Mar; 52(5):1336-41. PubMed ID: 1310643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
